Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May
NEW DELHI: Aurobindo Pharma expects to commercialise its vaccine manufacturing facility in Hyderabad by April-May next year, according to a top company official. The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19. Besides developing its […]